CytoTools AG
Symbool: T5O.DE
XETRA
0.406
EURMarktprijs vandaag
-4.2935
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
2.02M
MRK Kapitalisatie
- 0.00%
DIV Rendement
CytoTools AG (T5O-DE) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5.84 | 1.8 | 0 | 1.6 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-current-assets | 0.27 | 0.1 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.total-current-assets | 6.24 | 2 | 0.1 | 1.7 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 79.62 | 19.7 | 18.2 | 20.5 | ||||||||||||||
balance-sheet.row.tax-assets | -20.16 | 0 | 0 | 20.6 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0.53 | -19.7 | -18.2 | -20.6 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 79.66 | 19.7 | 18.2 | 20.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 85.89 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.account-payables | 0.16 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 0 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.08 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0.28 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0.33 | 0.1 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-liab | 0.77 | 0.2 | 0.4 | 0.4 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 20.55 | 5.1 | 4 | 4 | ||||||||||||||
balance-sheet.row.retained-earnings | -86.42 | -21.4 | -20.6 | -16.6 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 76.34 | 0.4 | 0.4 | 34.5 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.59 | 37.3 | 34 | 0 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 85.82 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 85.82 | - | - | - | ||||||||||||||
Total Investments | 79.62 | 19.7 | 18.2 | 20.3 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.net-debt | -5.84 | -1.8 | 0.1 | -1.6 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0.01 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.inventory | 0.01 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0.07 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -0.58 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1.5 | 0 | -4.8 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | -1.97 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1.97 | -1.5 | -0.1 | -4.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 4.4 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | -0.16 | 0 | 0 | 6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.16 | 4.2 | 0 | 6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -2.72 | 1.8 | -1.7 | -0.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | -2.72 | 1.8 | -0.1 | 1.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 1.6 | 2 | ||||||||||||||
cash-flows.row.operating-cash-flow | -0.58 | -0.9 | -1.6 | -1.7 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.free-cash-flow | -0.58 | -0.9 | -1.7 | -1.7 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0.5 | 0.7 | ||||||||||||||
income-statement-row.row.gross-profit | 0.02 | 0 | -0.5 | -0.7 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0.71 | 0.8 | 1.6 | 1.1 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0.71 | 0.8 | 1.6 | 1.9 | ||||||||||||||
income-statement-row.row.interest-income | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-caps | -0.68 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | -0.69 | -0.8 | -1.6 | -1.8 | ||||||||||||||
income-statement-row.row.income-before-tax | -0.66 | -0.8 | -4 | -1.8 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 |
Vaak gestelde vragen
Wat is CytoTools AG (T5O.DE) totale activa?
CytoTools AG (T5O.DE) totale activa is 21607950.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 12412.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 1.000.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -29.508.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -30.361.
Wat is CytoTools AG (T5O.DE) nettowinst (netto-inkomen)?
De nettowinst is -829837.250.
Wat is de totale schuld van het bedrijf?
De totale schuld is 0.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 835230.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 1081631.000.